SCHEMBL6485382

SCHEMBL6485382

CCOC(=O)c1c(-c2ccc(SC)cc2)c2n(c1-c1ccc(F)cc1)CCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.50
PTGS2 P35354 2/20 0.47
ALDH1A1 P00352 3/20 0.45
LMNA P02545 2/20 0.45
HTT P42858 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
PDE3B Q13370 2/20 0.45
PDE3A Q14432 2/20 0.45
KDM4E B2RXH2 1/20 0.42
GAA P10253 2/20 0.42
MAPK1 P28482 1/20 0.42
MEN1 O00255 2/20 0.41
PRKCZ Q05513 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA2 P47869 1/20 0.40
GABRB2 P47870 1/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6483652 0.92 KMT2A (0.50) KMT2APTGS2ALDH1A1LMNAHTT
SCHEMBL6290050 0.87 KMT2A (0.51) KMT2AALDH1A1LMNAHTTTDP1
SCHEMBL6294493 0.87 KMT2A (0.51) KMT2AALDH1A1LMNAHTTTDP1
SCHEMBL6995346 0.84 PTGS2 (0.46) KMT2APTGS2ALDH1A1LMNAHTT
SCHEMBL6294490 0.84 KMT2A (0.47) KMT2AALDH1A1LMNAHTTTDP1
SCHEMBL7002298 0.82 PTGS2 (0.46) KMT2APTGS2ALDH1A1LMNAHTT
SCHEMBL6475789 0.81 KMT2A (0.56) KMT2AALDH1A1LMNAHTTTDP1
SCHEMBL6291300 0.79 KMT2A (0.51) KMT2AALDH1A1LMNAHTTTDP1
SCHEMBL6291391 0.79 KMT2A (0.51) KMT2AALDH1A1LMNAHTTTDP1
SCHEMBL6477160 0.77 PTGS2 (0.50) KMT2APTGS2ALDH1A1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6936632-B2 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof MERCKLE GMBH (DE) 2005-08-30 US disclosed
US-20040122002-A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof MERCKLE GMBH (DE) 2004-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122002-A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof PTGS1, PTGS2, PTGER1 KMT2A 3737/4885PTGS2 2/4885ALDH1A1 302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.